ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 168 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,000 | -28.1% | 24,358 | +3.2% | 0.00% | – |
| Q2 2023 | $32,000 | -97.4% | 23,593 | -28.0% | 0.00% | -100.0% |
| Q3 2020 | $1,217,000 | +12.8% | 32,753 | +51.9% | 0.01% | 0.0% |
| Q2 2020 | $1,079,000 | +58.7% | 21,568 | -10.1% | 0.01% | +50.0% |
| Q1 2020 | $680,000 | -50.9% | 23,993 | -2.7% | 0.00% | -50.0% |
| Q4 2019 | $1,386,000 | +80.2% | 24,668 | +9.4% | 0.01% | +100.0% |
| Q3 2019 | $769,000 | -41.0% | 22,549 | -19.8% | 0.00% | -50.0% |
| Q2 2019 | $1,304,000 | +69.4% | 28,115 | +46.5% | 0.01% | +60.0% |
| Q1 2019 | $770,000 | -6.7% | 19,189 | +6.8% | 0.01% | -16.7% |
| Q4 2018 | $825,000 | +6.0% | 17,961 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $778,000 | – | 17,550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |